Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel
NASDAQ:HYPR

Hyperfine Q3 2026 Earnings Date & Estimates

Hyperfine logo
$0.77 -0.03 (-3.89%)
As of 02:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hyperfine is scheduled to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Hyperfine in Q3 2026

Hyperfine is expected to post earnings of -$0.08 per share on revenue of $5.79 million. In the same quarter a year earlier Hyperfine reported -$0.11 per share on revenue of $3.44 million. Hyperfine last reported on August 6, 2026, posting -$0.09 per share and matching the -$0.09 consensus estimate. Hyperfine has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.08
Expected Revenue
$5.79 million
Prior-Year EPS
-$0.11
Prior-Year Revenue
$3.44 million
Expected Revenue Growth
+68.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.09 (Met Expectations)
Last Quarter Revenue
$3.90 million
EPS Beat Rate
2 of last 8 quarters

Prepare for the Q3 2026 Call

Hyperfine Q3 2026 Earnings FAQ

Hyperfine (NASDAQ:HYPR) has confirmed it will report Q3 2026 earnings on Monday, November 9, 2026, after market closes.

Hyperfine's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Hyperfine to post earnings of -$0.08 per share for Q3 2026.

The consensus revenue estimate for Hyperfine is $5.79 million for Q3 2026.

Hyperfine Earnings Headlines

Analyzing Spectral AI (NASDAQ:MDAI) and Hyperfine (NASDAQ:HYPR)
October 13 at 4:45 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31114216
Contrasting Hyperfine (NASDAQ:HYPR) and Beta Bionics (NASDAQ:BBNX)
October 12 at 5:14 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31109922
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
October 15 at 1:00 AM  |  Profits Run (Ad)
Hyperfine reports record preliminary Q3 revenue of $6 million, up 53% sequentially
October 8, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/hyperfine-reports-record-preliminary-q3-revenue-of-6-million-up-53-sequentially/ar-AA2dP8HK
Hyperfine expects Q3 revenue of $6M; shares jump 9%
October 8, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/hyperfine-expects-q3-revenue-of-6m-shares-jump-9/ar-AA2dODRo
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
October 8, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20261008951075/en/Hyperfine-Reports-Record-Preliminary-Third-Quarter-Revenue-of-Approximately-6.0-Million-Reaffirms-Full-Year-2026-Revenue-Outlook-of-Approximately-20-to-22-Million/
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR) (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging (MRI) more accessible and convenient. Its flagship product, the Swoop Portable MR Imaging System, is designed to provide brain imaging at or near the patient’s bedside rather than requiring transport to a traditional MRI suite.

The Swoop system uses a low-field magnetic resonance platform, artificial intelligence-enabled image processing and a mobile design to support neuroimaging in settings such as hospitals, intensive care units and other clinical environments. The company’s technology is intended to help clinicians evaluate conditions including stroke, brain injury and other neurological disorders when conventional MRI access may be limited or patient transport may present challenges.

Hyperfine was founded in 2014 and is headquartered in Guilford, Connecticut. Its products have been developed for healthcare providers in the United States and international markets, subject to applicable regulatory clearances and approvals. The company became publicly traded on the Nasdaq following a business combination completed in 2021.

View Hyperfine Profile
Earnings Tools